2022.11.9 Axil Capital Launches its Second Life Science Fund (ALHF II)

Axil Capital announced today the launch of Axil Life Science & Healthcare Fund II (“ALHF II”)

As with ALHF I, ALHF II will focus on investing and supporting life science and health-tech startups by leveraging its industry expertise and global network. The fund aims to produce world-class companies from Japan by liaising with the global venture ecosystem and enabling the venture managers to adopt a global perspective focused on commercial success.
 

<Fund Summary>

Name

Axil Life Science & Healthcare Fund II Investment Limited Partnership (ALHF II L.P.)

GP

Axil Capital Partners II Limited Liability Partnership

Target Area

Biopharmaceutical, Life Science, Medical Technology and Healthcare Technology

Target Regions

Primarily Japan, with diversification across U.S., EU and Asia

Target Stage

Diversified investments from seed/early to middle/later

Axil Capital-07.png

Axil Capital Advisors K.K.

Nittochi Nishi-shinbashi Bldg. 7F

1-11-4 Nishi-shinbashi

Minato-ku, Tokyo 105-0003, JAPAN

© Axil Capital All Rights Reserved